Saturday, 27 November 2010

Trelstar


Trelstar is a brand name of triptorelin, approved by the FDA in the following formulation(s):


TRELSTAR (triptorelin pamoate - injectable; intramuscular)



  • Manufacturer: WATSON LABS

    Approval date: June 15, 2000

    Strength(s): EQ 3.75MG BASE/VIAL [RLD]


  • Manufacturer: WATSON LABS

    Approval date: June 29, 2001

    Strength(s): EQ 11.25MG BASE/VIAL [RLD]


  • Manufacturer: WATSON LABS

    Approval date: March 10, 2010

    Strength(s): EQ 22.5MG BASE/VIAL [RLD]

Has a generic version of Trelstar been approved?


No. There is currently no therapeutically equivalent version of Trelstar available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Trelstar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Sustained and controlled release of water insoluble polypeptides
    Patent 5,776,885
    Issued: July 7, 1998
    Inventor(s): Orsolini; Piero & Mauvernay; Rolland-Yves & Deghenghi; Romano
    Assignee(s): Debio Recherche Pharmaceutique SA
    A pharmaceutical composition for the sustained release of a peptide wherein the composition includes a polylactide polymer, a polymer of lactic acid and glycolic acid, or a mixture of such polymers and a therapeutically active peptide in the form of its pamoate, tannate or stearate salt. The composition when placed in an aqueous physiological environment releases the peptide in a continuous manner for a period of at least about one week.
    Patent expiration dates:

    • July 7, 2015


    • July 7, 2015
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 10, 2013 - NEW PRODUCT

See also...

  • Trelstar Advanced Consumer Information (Micromedex)
  • Trelstar AHFS DI Monographs (ASHP)
  • Triptorelin Consumer Information (Wolters Kluwer)
  • Triptorelin Consumer Information (Cerner Multum)
  • Triptorelin Intramuscular, Injection Advanced Consumer Information (Micromedex)
  • Triptorelin Pamoate AHFS DI Monographs (ASHP)

Friday, 26 November 2010

Relenza




In the US, Relenza (zanamivir systemic) is a member of the following drug classes: inhaled anti-infectives, neuraminidase inhibitors and is used to treat Influenza, Influenza Prophylaxis and Swine Flu.

US matches:

  • Relenza

Ingredient matches for Relenza



Zanamivir

Zanamivir is reported as an ingredient of Relenza in the following countries:


  • Australia

  • Austria

  • Belgium

  • Bulgaria

  • Canada

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • France

  • Georgia

  • Germany

  • Hong Kong

  • Iceland

  • Israel

  • Italy

  • Japan

  • Latvia

  • Lithuania

  • Luxembourg

  • Malta

  • Mexico

  • Myanmar

  • Netherlands

  • New Zealand

  • Norway

  • Oman

  • Poland

  • Portugal

  • Romania

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Wednesday, 24 November 2010

Neporex




Neporex may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Neporex



Cyromazine

Cyromazine is reported as an ingredient of Neporex in the following countries:


  • Portugal

  • South Africa

International Drug Name Search

Thursday, 18 November 2010

Norfloxacinã




Norfloxacinã may be available in the countries listed below.


Ingredient matches for Norfloxacinã



Norfloxacin

Norfloxacin is reported as an ingredient of Norfloxacinã in the following countries:


  • Romania

International Drug Name Search

Wednesday, 17 November 2010

Nedocromil Sodium




Nedocromil Sodium may be available in the countries listed below.


Ingredient matches for Nedocromil Sodium



Nedocromil

Nedocromil Sodium (BANM, USAN) is known as Nedocromil in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Erphathrocin




Erphathrocin may be available in the countries listed below.


Ingredient matches for Erphathrocin



Erythromycin

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Erphathrocin in the following countries:


  • Indonesia

Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Erphathrocin in the following countries:


  • Indonesia

International Drug Name Search